February 25, 2019
Terranueva is awarded cultivation, transformation and sale (medical) licences from Health Canada
Montreal, QC – Terranueva Corporation (CSE: TEQ) (« Terranueva » or the « Corporation ») is proud to announce that its wholly‐owned subsidiary, Terranueva Pharma Corporation, was awarded on February 22, 2019, in accordance with the new Cannabis Act, cultivation, transformation and sale (medical) licences by Health Canada (the « Licences »). These Licences authorize Terranueva to produce, process and sell seeds and plants to wholesalers/distributors supplying the provincial and territorial cannabis retailers and/or individuals who have registered to obtain cannabis products for medical purposes ("registered patients"). Moreover, Terranueva may conduct related activities such as possession, transportation, storage, destruction, research and development and sell of bulk cannabis to other federal licence holders.